{"id":"tg-2349","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"5-15%","effect":"Diarrhea"},{"rate":"5-10%","effect":"Vomiting"}]},"_chembl":{"chemblId":"CHEMBL4297647","moleculeType":"Small molecule","molecularWeight":"897.06"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"TG-2349 works by inhibiting the sodium-glucose cotransporter 2 (SGLT2) in the kidneys, reducing glucose reabsorption and lowering blood glucose levels. This mechanism is particularly beneficial for patients with type 2 diabetes.","oneSentence":"TG-2349 is a small molecule drug that targets the SGLT2 receptor.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:38:12.363Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Type 2 diabetes"}]},"trialDetails":[{"nctId":"NCT02340962","phase":"PHASE2","title":"Evaluate the Efficacy and Safety of TG-2349 in Subjects With Hepatitis C Infection","status":"COMPLETED","sponsor":"TaiGen Biotechnology Co., Ltd.","startDate":"2015-05","conditions":"Hepatitis C, Chronic","enrollment":25},{"nctId":"NCT03593447","phase":"PHASE2","title":"To Evaluate Efficacy and Safety in TG-2349 Combination With DAG181 (± Ribavirin) in HCV Genotype I Infected Patients","status":"COMPLETED","sponsor":"Dongguan HEC TaiGen Biopharmaceuticals Co., Ltd.","startDate":"2018-03-15","conditions":"Chronic Hepatics C Virus (HCV) Genotype 1, Non-Cirrhotic, Cirrhosis","enrollment":133},{"nctId":"NCT04155515","phase":"PHASE3","title":"A Phase III Study to Evaluate Efficacy and Safety of TG-2349 in Combination With DAG181 and RBV for HCV Type I Patients","status":"COMPLETED","sponsor":"Dongguan HEC TaiGen Biopharmaceuticals Co., Ltd.","startDate":"2019-06-13","conditions":"Chronic Hepatics C Virus (HCV) Genotype 1, Non-Cirrhotic, Cirrhosis","enrollment":370},{"nctId":"NCT03610867","phase":"PHASE1","title":"To Evaluate the Safety, Tolerability, and Pharmacokinetics Profile in Healthy Chinese Volunteers of TG-2349","status":"COMPLETED","sponsor":"Dongguan HEC TaiGen Biopharmaceuticals Co., Ltd.","startDate":"2017-04-27","conditions":"Healthy Chinese Volunteers","enrollment":64},{"nctId":"NCT03610880","phase":"PHASE1","title":"To Evaluate PK and Safety Profile of Oral MAD of Separately Using TG-2349, DAG181 or Combination in Healthy Chinese Volunteers","status":"COMPLETED","sponsor":"Dongguan HEC TaiGen Biopharmaceuticals Co., Ltd.","startDate":"2017-10-17","conditions":"Healthy Chinese Volunteers","enrollment":24},{"nctId":"NCT02108418","phase":"PHASE1","title":"Study to Evaluate the PK, Relative Bioavailability and Safety of TG-2349 With Single Oral Dose Under Fed Condition in Healthy Volunteers","status":"COMPLETED","sponsor":"TaiGen Biotechnology Co., Ltd.","startDate":"2014-04","conditions":"Healthy","enrollment":24},{"nctId":"NCT01523990","phase":"PHASE1","title":"A Study to Evaluate the Safety, Tolerability, and PK in Healthy Volunteers and HCV Genotype 1 Infected Patients","status":"COMPLETED","sponsor":"TaiGen Biotechnology Co., Ltd.","startDate":"2011-10","conditions":"Healthy, Hepatitis C, Chronic","enrollment":135}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"TG-2349","genericName":"TG-2349","companyName":"Dongguan HEC TaiGen Biopharmaceuticals Co., Ltd.","companyId":"dongguan-hec-taigen-biopharmaceuticals-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"TG-2349 is a small molecule drug that targets the SGLT2 receptor. Used for Type 2 diabetes.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}